These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4869717)
1. Experimental treatment of parkinsonism with L-Dopa. Cotzias GC; Papavasiliou PS; Gellene R Neurology; 1968 Mar; 18(3):276-7. PubMed ID: 4869717 [No Abstract] [Full Text] [Related]
2. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]. Birkmayer W; Linauer W; Mentasti M; Riederer P Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492 [No Abstract] [Full Text] [Related]
3. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
5. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]. Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985 [No Abstract] [Full Text] [Related]
9. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744 [No Abstract] [Full Text] [Related]
10. Metabolism and clinical assessment of L-dopa in parkinsonism. Ericsson AD; McCann D; Sharpless N; Reveno W Neurology; 1970 Apr; 20(4):402. PubMed ID: 4935027 [No Abstract] [Full Text] [Related]
11. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
12. Treatment of severe parkinsonism with L-dopa. Reef HE; Joffe R; Milletz H S Afr Med J; 1971 May; 45(18):504-7. PubMed ID: 4941208 [No Abstract] [Full Text] [Related]
13. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism. Knutsson E; Mårtensson A; Meyerson BA; Risberg AM Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551 [No Abstract] [Full Text] [Related]
14. Combined treatment of parkinsonism with L-dopa and amantadine. Hunter KR; Stern GM; Laurence DR; Armitage P Lancet; 1970 Sep; 2(7672):566. PubMed ID: 4195220 [No Abstract] [Full Text] [Related]
16. [Effects of L-dopa and stereotaxic surgery in Parkinsonism]. Sugita K; Mutsuga N; Takaoka Y; Takeda A No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927 [No Abstract] [Full Text] [Related]
17. Parkinsonism and DOPA. Cotzias GC; Papavasiliou PS; Gellene R; Aronson RB Trans Assoc Am Physicians; 1968; 81():171-83. PubMed ID: 4889342 [No Abstract] [Full Text] [Related]